No results found for “”
No results found for filter “”
-
Blog articles 25.02.21
From diagnosis to awareness
Innovation has to be about patients, and everyone who lives with a disease, however common or rare, deserves the chance for a normal life.
Read Article -
Blog articles 25.02.21
New Normal, Same Cancer (Guest blog)
Strong coordinated efforts are needed to reduce the future impacts of the pandemic on cancer patients
Read Article -
Blog articles 24.02.21
#WeWontRest until we make treatments for rare disease less rare
Some diseases are rare. Treating them shouldn't be.
Read Article -
Blog articles 24.02.21
IP and COVID – part of the solution not part of the problem
Fostering a research eco-system that can deliver that innovation rather than undermining it through challenges to IP like compulsory licensing, is the...
Read Article -
Statements & press releases 23.02.21
Unlocking the potential of precision medicine in Europe – Improving cancer care through broader access...
Biomarkers and biomarker testing are a significant pillar of precision medicine, which uses patient data to inform personalised treatment decisions.
Read Article -
Statements & press releases 23.02.21
Transforming health research & innovation in Europe: A Joint Statement on the European Partnership for...
Health industry stakeholders welcome the Commission’s proposal for a European Partnership for Health Innovation under Horizon Europe.
Read Article -
Blog articles 23.02.21
One pandemic, two lenses: Why I am part of #TeamVaccines
We can all make a difference by getting vaccinated; protecting ourselves, protecting our friends and families, protecting each other
Read Article -
Statements & press releases 22.02.21
EFPIA statement on EU Trade Strategy
The COVID-19 pandemic has underlined the importance of global cooperation and well-functioning global supply chains
Read Article -
Blog articles 18.02.21
Pragmatic Solutions Needed for Lifecycle Management of Drug-Device Combinations (Guest Blog)
May 26, 2021 is the fast approaching date of application of the Medical Devices Regulation and with it, the requirement for Industry to ensure compliance...
Read Article -
Blog articles 18.02.21
Podcast: Fighting the fakes - what's industry's role?
Welcome to 19 conversations
Read Article -
Blog articles 18.02.21
What’s next in diabetes care - 100 years since the lifesaving discovery of insulin (Guest blog)
The discovery of insulin in 1921 marked the start of a medical journey that has fundamentally changed the lives of people with diabetes
Read Article -
Blog articles 18.02.21
Ready for take-off – The launch of Europe’s Beating Cancer Plan (Guest blog)
What should we aim for by 2030?
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 03.12.20
Working together towards better patient outcomes
A new series of short films to showcase innovative partnerships that will change patient outcomes
Read Article -
EFPIA News 14.10.20
Biopharmaceutical industry support EU regulators exceptional transparency measures
And call other regulatory authorities to follow suit to help ensure confidence in the science and the decision-making
Read Article -
EFPIA News 17.09.20
Vaccines Europe Statement on the safety of COVID-19 vaccines
The health and safety of people receiving any vaccine is our first priority, and that applies equally to recipients of a COVID-19 vaccine
Read Article -
EFPIA News 10.06.20
Connecting Healthcare Awards - Submission period extended
The new deadline is 30 September 2020
Read Article -
EFPIA News 23.04.20
Europe’s COVID-19 battle: Getting the data we need to ensure the supply of medicines
A major part of the solution is the provision of detailed, accurate forecasting data from the European Centre for Disease Control (ECDC) on the patient-level...
Read Article -
EFPIA News 22.04.20
Coronavirus – your questions answered
What is the industry in Europe doing to help in the fight against the coronavirus? What are the risks of drug shortage caused by the coronavirus?
Read Article -
EFPIA News 20.04.20
Exscalate4Cov project: Call for Collaboration by DG Connect
The European Commission (DG Connect) is looking for industry partners to join the Exscalate4Cov project, seeking to accelerate identification of medicines...
Read Article -
EFPIA News 08.04.20
Official Update on the Connecting Healthcare Awards
A special COVID-19 category now available
Read Article -
EFPIA News 05.03.20
Connecting Healthcare Awards 2020 – Apply Now
Turn the spotlight on collaborative projects that make a difference to patients across Europe
Read Article -
EFPIA News 05.03.20
EFPIA's input to the EU's Beating Cancer Plan Roadmap consultation
The research-based pharmaceutical industry remains committed to improving cancer prevention, diagnosis, treatment and quality of life of patients.
Read Article -
EFPIA News 20.02.20
IMI opens registrations for a webinar on the Coronavirus Call
The Innovative Medicines Initiative to launch EUR 45 million Call for proposals on COVID-19 early March
Read Article -
EFPIA News 10.02.20
EFPIA, Medicines for Europe and AESGP call for a Mutual Recognition Agreement on Good Manufacturing Practice...
The pharmaceutical industry in Europe has worked to support the EU27 and UK to reach an agreement that will allow patients to receive medicines and medical...
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 23.02.21
Unlocking the potential of precision medicine in Europe – Improving cancer care through broader access...
Biomarkers and biomarker testing are a significant pillar of precision medicine, which uses patient data to inform personalised treatment decisions.
Read Article -
Statements & press releases 23.02.21
Transforming health research & innovation in Europe: A Joint Statement on the European Partnership for...
Health industry stakeholders welcome the Commission’s proposal for a European Partnership for Health Innovation under Horizon Europe.
Read Article -
Statements & press releases 22.02.21
EFPIA statement on EU Trade Strategy
The COVID-19 pandemic has underlined the importance of global cooperation and well-functioning global supply chains
Read Article -
Statements & press releases 09.02.21
EFPIA response to the Cross-border Healthcare Directive
Giving patients access to safe and high-quality healthcare and encouraging cooperation across the European Union
Read Article -
Statements & press releases 09.02.21
Using the FMD Data Repositories for Shortages Monitoring
Patient health and safety is of the utmost importance to the stakeholders that have put every effort in place to implement safety features and set up the...
Read Article -
Statements & press releases 03.02.21
AESGP, EFPIA and Medicines for Europe joint reflections on EMA-HMA-EC Key principles for electronic Product...
This paper aims to highlight key asks and identify key actions in order to move the ePI project from principles to action.
Read Article -
Statements & press releases 03.02.21
Cancer experts, patients and industry applaud Europe’s Beating Cancer Plan and reemphasise the importance...
The Plan will guide country efforts and includes commitment to shared goals and actions
Read Article -
Statements & press releases 02.02.21
EFPIA response to the European Health Union consultations
Strengthening Europe’s capacity to prepare and respond to public health threats
Read Article -
Statements & press releases 29.01.21
EFPIA Statement in response to EU Export Restrictions for COVID-19 vaccines
The establishment by the European Commission of an export authorisation system for Member States to use regarding COVID-19 vaccines, risks delaying and...
Read Article -
Statements & press releases 28.01.21
EFPIA-Vaccines Europe statement on COVID-19 vaccines supply
Read Article -
Statements & press releases 27.01.21
EFPIA-Vaccines Europe statement on COVID-19 vaccines distribution
Scientists and experts are working day and night to address these challenges, increasing the capacity of manufacturing facilities and fine-tuning processes....
Read Article -
Statements & press releases 14.01.21
EFPIA response to Inception Impact Assessment on Orphan and Paediatric Regulations
EFPIA members are committed to ensuring that unmet needs are addressed and that available treatments reach all European patients
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 25.02.21
From diagnosis to awareness
Innovation has to be about patients, and everyone who lives with a disease, however common or rare, deserves the chance for a normal life.
Read Article -
Blog articles 25.02.21
New Normal, Same Cancer (Guest blog)
Strong coordinated efforts are needed to reduce the future impacts of the pandemic on cancer patients
Read Article -
Blog articles 24.02.21
#WeWontRest until we make treatments for rare disease less rare
Some diseases are rare. Treating them shouldn't be.
Read Article -
Blog articles 24.02.21
IP and COVID – part of the solution not part of the problem
Fostering a research eco-system that can deliver that innovation rather than undermining it through challenges to IP like compulsory licensing, is the...
Read Article -
Blog articles 23.02.21
One pandemic, two lenses: Why I am part of #TeamVaccines
We can all make a difference by getting vaccinated; protecting ourselves, protecting our friends and families, protecting each other
Read Article -
Blog articles 18.02.21
Pragmatic Solutions Needed for Lifecycle Management of Drug-Device Combinations (Guest Blog)
May 26, 2021 is the fast approaching date of application of the Medical Devices Regulation and with it, the requirement for Industry to ensure compliance...
Read Article -
Blog articles 18.02.21
Podcast: Fighting the fakes - what's industry's role?
Welcome to 19 conversations
Read Article -
Blog articles 18.02.21
What’s next in diabetes care - 100 years since the lifesaving discovery of insulin (Guest blog)
The discovery of insulin in 1921 marked the start of a medical journey that has fundamentally changed the lives of people with diabetes
Read Article -
Blog articles 18.02.21
Ready for take-off – The launch of Europe’s Beating Cancer Plan (Guest blog)
What should we aim for by 2030?
Read Article -
Blog articles 11.02.21
Podcast: Can a shared understanding of unmet medical needs support innovation?
Welcome to 19 conversations
Read Article -
Blog articles 04.02.21
IMI Impact: Beating cancer – together (Guest blog)
With €190 million invested since 2008, the Innovative Medicines Initiative (IMI) is advancing the fight against cancer
Read Article -
Blog articles 02.02.21
Improving cancer literacy in Europe to save time, costs and lives (Guest blog)
Improved cancer literacy of patients and communication skills of health professionals involved in cancer-related services will support a more cohesive...
Read Article